| Old Articles: <Older 8671-8680 Newer> |
|---|
 |
Chemistry World
September 11, 2013
Emma Stoye |
Call to overhaul liver toxicity testing Outdated assays for monitoring liver health could have caused dozens of drug candidates to be wrongly scrapped during development, according to new research.   |
Chemistry World
September 10, 2013
Phillip Broadwith |
GSK divests Lucozade and Ribena brands GlaxoSmithKline has agreed to sell drinks brands Lucozade and Ribena to Japanese food and beverage maker Suntory. The move is the latest in a series of divestitures. |
Chemistry World
September 6, 2013
Phillip Broadwith |
Otsuka to buy Astex for $886 million Japanese firm Otsuka has agreed to buy the Anglo-American Astex Pharmaceuticals for $886 million in cash. |
Chemistry World
September 6, 2013
Dinsa Sachan |
Another drug suspension overturned in India An Indian high court has quashed the suspension of a popular antidepressant. This comes shortly after the suspension of the diabetes drug pioglitazone was overturned. |
Chemistry World
September 4, 2013
Sarah Houlton |
Amgen snaps up Onyx in huge biotech deal The $10.4 billion deal gives Amgen access to the recently approved multiple myeloma drug carfilzomib (Kyprolis), plus several other partnered anticancer agents that are already on the market. |
Information Today
September 3, 2013 |
SwetsWise Medical Searcher Boosts Discovery Swets rolled out its SwetsWise Medical Searcher Starter Package, which will accelerate discovery for physicians, researchers, and healthcare professionals. |
Chemistry World
September 3, 2013
Patrick Walter |
Lundbeck appeals European antitrust fine Lundbeck is appealing against a euro 93.8 million fine, handed down by the European commission, for its part in blocking market entry of a generic antidepressant. |
Chemistry World
September 2, 2013
Emma Stoye |
Endo Health to buy Boca Pharmacal for $225m US speciality healthcare company Endo Health Solutions has agreed to buy Boca Pharmacal for $225 million in a bid to expand its generics business. |
Chemistry World
August 30, 2013
Laura Howes |
Nice rules against Afinitor The National Institute for Health and Care Excellence (Nice), which evaluates treatments based on cost effectiveness, has confirmed that patients with advanced breast cancer will not be prescribed the Novartis drug Afinitor (everolimus). |
Chemistry World
August 29, 2013
Emma Stoye |
Couple charged in GSK corruption investigation A UK consultant and his American wife have been charged in relation to the corruption investigation at GlaxoSmithKline in China. |
| <Older 8671-8680 Newer> Return to current articles. |
